首页 > 最新文献

Journal of Smooth Muscle Research最新文献

英文 中文
Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension. TRPM7通道作为肺动脉高压新治疗靶点的潜力
Q3 Medicine Pub Date : 2022-01-01 DOI: 10.1540/jsmr.58.50
Keizo Hiraishi, Lin Hai Kurahara, Kaori Ishikawa, Tetsuhiko Go, Naoya Yokota, Yaopeng Hu, Takayuki Fujita, Ryuji Inoue, Katsuya Hirano

Pulmonary arterial hypertension (PAH) is an intractable vascular disease characterized by a progressive increase in pulmonary vascular resistance caused by pulmonary vascular remodeling, which ultimately leads to right-sided heart failure. PAH remains incurable, despite the development of PAH-targeted therapeutics centered on pulmonary artery relaxants. It is necessary to identify the target molecules that contribute to pulmonary artery remodeling. Transient receptor potential (TRP) channels have been suggested to modulate pulmonary artery remodeling. Our study focused on the transient receptor potential ion channel subfamily M, member 7, or the TRPM7 channel, which modulates endothelial-to-mesenchymal transition and smooth muscle proliferation in the pulmonary artery. In this review, we summarize the role and expression profile of TRPM7 channels in PAH progression and discuss TRPM7 channels as possible therapeutic targets. In addition, we discuss the therapeutic effect of a Chinese herbal medicine, Ophiocordyceps sinensis (OCS), on PAH progression, which partly involves TRPM7 inhibition.

肺动脉高压(Pulmonary arterial hypertension, PAH)是一种难治性血管疾病,其特征是肺血管重构导致肺血管阻力进行性增加,最终导致右侧心力衰竭。尽管以肺动脉松弛剂为中心的多环芳烃靶向治疗的发展,多环芳烃仍然无法治愈。有必要确定有助于肺动脉重塑的靶分子。瞬时受体电位(TRP)通道被认为可以调节肺动脉重构。我们的研究重点是瞬时受体电位离子通道亚家族M,成员7,或TRPM7通道,它调节肺动脉内皮到间质转化和平滑肌增殖。在这篇综述中,我们总结了TRPM7通道在PAH进展中的作用和表达谱,并讨论了TRPM7通道作为可能的治疗靶点。此外,我们还讨论了中草药“冬虫夏草”(Ophiocordyceps sinensis, OCS)对PAH进展的治疗作用,其中部分涉及抑制TRPM7。
{"title":"Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension.","authors":"Keizo Hiraishi,&nbsp;Lin Hai Kurahara,&nbsp;Kaori Ishikawa,&nbsp;Tetsuhiko Go,&nbsp;Naoya Yokota,&nbsp;Yaopeng Hu,&nbsp;Takayuki Fujita,&nbsp;Ryuji Inoue,&nbsp;Katsuya Hirano","doi":"10.1540/jsmr.58.50","DOIUrl":"https://doi.org/10.1540/jsmr.58.50","url":null,"abstract":"<p><p>Pulmonary arterial hypertension (PAH) is an intractable vascular disease characterized by a progressive increase in pulmonary vascular resistance caused by pulmonary vascular remodeling, which ultimately leads to right-sided heart failure. PAH remains incurable, despite the development of PAH-targeted therapeutics centered on pulmonary artery relaxants. It is necessary to identify the target molecules that contribute to pulmonary artery remodeling. Transient receptor potential (TRP) channels have been suggested to modulate pulmonary artery remodeling. Our study focused on the transient receptor potential ion channel subfamily M, member 7, or the TRPM7 channel, which modulates endothelial-to-mesenchymal transition and smooth muscle proliferation in the pulmonary artery. In this review, we summarize the role and expression profile of TRPM7 channels in PAH progression and discuss TRPM7 channels as possible therapeutic targets. In addition, we discuss the therapeutic effect of a Chinese herbal medicine, Ophiocordyceps sinensis (OCS), on PAH progression, which partly involves TRPM7 inhibition.</p>","PeriodicalId":39619,"journal":{"name":"Journal of Smooth Muscle Research","volume":" ","pages":"50-62"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/48/76/jsmr-58-050.PMC9364263.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40597606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Relationships between advanced glycation end products (AGEs), vasoactive substances, and vascular function. 晚期糖基化终产物(AGEs)、血管活性物质和血管功能之间的关系。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.1540/jsmr.57.94
Takayuki Matsumoto, Kumiko Taguchi, Tsuneo Kobayashi

Vascular smooth muscle cells (VSMCs) and endothelial cells (ECs) are major cell types that control vascular function, and hence dysfunction of these cells plays a key role in the development and progression of vasculopathies. Abnormal vascular responsiveness to vasoactive substances including vasoconstrictors and vasodilators has been observed in various arteries in diseases including diabetes, hypertension, chronic kidney diseases, and atherosclerosis. Several substances derived from ECs tightly control vascular function, such as endothelium-derived relaxing and contracting factors, and it is known that abnormal vascular signaling of these endothelium-derived substances is often observed in various diseases. Derangement of signaling in VSMCs and altered function influence vascular reactivity to vasoactive substances and tone, which are important determinants of vascular resistance and blood pressure. However, understanding the molecular mechanisms underlying abnormalities of vascular functions in pathological states is difficult because multiple substances interact in the development of these processes. Advanced glycation end products (AGEs), a heterogeneous group of bioactive compounds, are thought to contribute to vascular dysfunction, which in turn cause the development of several diseases including diabetes, hypertension, stroke, and atherosclerosis. A growing body of evidence suggests that AGEs could affect these cells and modulate vascular function. This study is focused on the link between AGEs and functions of ECs and VSMCs, particularly the modulative effects of AGEs on vascular reactivities to vasoactive substances.

血管平滑肌细胞(VSMCs)和内皮细胞(ECs)是控制血管功能的主要细胞类型,因此这些细胞的功能障碍在血管病变的发生和发展中起着关键作用。在糖尿病、高血压、慢性肾脏疾病和动脉粥样硬化等疾病的各种动脉中,都观察到血管对血管收缩剂和血管舒张剂等血管活性物质的异常反应。内皮细胞衍生的几种物质紧密控制血管功能,如内皮源性舒张因子和收缩因子,已知这些内皮源性物质的异常血管信号在各种疾病中经常观察到。VSMCs信号紊乱和功能改变影响血管对血管活性物质和张力的反应性,这是血管阻力和血压的重要决定因素。然而,理解病理状态下血管功能异常的分子机制是困难的,因为多种物质在这些过程的发展中相互作用。晚期糖基化终产物(AGEs)是一组异质性的生物活性化合物,被认为有助于血管功能障碍,从而导致多种疾病的发展,包括糖尿病、高血压、中风和动脉粥样硬化。越来越多的证据表明,AGEs可以影响这些细胞并调节血管功能。本研究的重点是AGEs与内皮细胞和VSMCs功能之间的联系,特别是AGEs对血管活性物质反应的调节作用。
{"title":"Relationships between advanced glycation end products (AGEs), vasoactive substances, and vascular function.","authors":"Takayuki Matsumoto,&nbsp;Kumiko Taguchi,&nbsp;Tsuneo Kobayashi","doi":"10.1540/jsmr.57.94","DOIUrl":"https://doi.org/10.1540/jsmr.57.94","url":null,"abstract":"<p><p>Vascular smooth muscle cells (VSMCs) and endothelial cells (ECs) are major cell types that control vascular function, and hence dysfunction of these cells plays a key role in the development and progression of vasculopathies. Abnormal vascular responsiveness to vasoactive substances including vasoconstrictors and vasodilators has been observed in various arteries in diseases including diabetes, hypertension, chronic kidney diseases, and atherosclerosis. Several substances derived from ECs tightly control vascular function, such as endothelium-derived relaxing and contracting factors, and it is known that abnormal vascular signaling of these endothelium-derived substances is often observed in various diseases. Derangement of signaling in VSMCs and altered function influence vascular reactivity to vasoactive substances and tone, which are important determinants of vascular resistance and blood pressure. However, understanding the molecular mechanisms underlying abnormalities of vascular functions in pathological states is difficult because multiple substances interact in the development of these processes. Advanced glycation end products (AGEs), a heterogeneous group of bioactive compounds, are thought to contribute to vascular dysfunction, which in turn cause the development of several diseases including diabetes, hypertension, stroke, and atherosclerosis. A growing body of evidence suggests that AGEs could affect these cells and modulate vascular function. This study is focused on the link between AGEs and functions of ECs and VSMCs, particularly the modulative effects of AGEs on vascular reactivities to vasoactive substances.</p>","PeriodicalId":39619,"journal":{"name":"Journal of Smooth Muscle Research","volume":"57 0","pages":"94-107"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3a/0c/jsmr-57-094.PMC8795595.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39871487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Spatial lay-out of various smooth muscles. 各种平滑肌的空间布局。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.1540/jsmr.57.19
Giorgio Gabella

The characteristic mechanical activities of the smooth muscles found in all organs of the body are highly variable and depend mainly on the spatial arrangement of the muscle cells and the stroma: mass, orientation, relationships, links, constraints, which are deployed in various configurations. These structural features are examined here for their mechanical relevance, in light and electron microscopic views of several muscles of viscera and blood vessels, in a selection of mammalian species. Smooth muscles are incompressible and therefore maintain constant volume. They do not have available space and any movement of a part requires displacement of another part. Most of them have no terminations or points of attachment, and in hollow organs such as intestines, blood vessels and uro-genital tract they usually form structures closed onto themselves, such as rings or bag-like containers In these situations, changes in the size of the lumen is achieved very efficiently by a concentric inward enlargement that accompanies muscle contraction. The longitudinal arrangement of collagen blocks an elongation of small blood vessels upon contraction, further enhancing the efficiency of lumen reduction. In other muscles, links between layers and special arrangements of the stroma allow both shortening and elongation of a tubular organ to occur. The mechanics of smooth muscles has many characteristic features (some unique, some shared with those of hydrostats, some at variance with other muscles) and histological data are a contribution to our understanding of these properties.

在身体所有器官中发现的平滑肌的特征机械活动是高度可变的,主要取决于肌肉细胞和基质的空间排列:质量、方向、关系、联系、约束,它们以各种形式部署。这些结构特征在这里检查其机械相关性,在一些哺乳动物物种的内脏和血管的肌肉的光学和电子显微镜视图。平滑肌是不可压缩的,因此保持恒定的体积。它们没有可用的空间,一个部件的任何移动都需要另一个部件的位移。它们大多数没有末端或附着点,在肠、血管和泌尿生殖道等中空器官中,它们通常形成封闭的结构,如环或袋状容器。在这些情况下,腔的大小变化是通过同心向内扩大和肌肉收缩来非常有效地实现的。胶原蛋白的纵向排列阻断了收缩时小血管的伸长,进一步提高了管腔缩小的效率。在其他肌肉中,层与层之间的联系和基质的特殊排列允许管状器官的缩短和伸长。平滑肌的力学有许多特征(有些是独特的,有些与静水肌相同,有些与其他肌肉不同),组织学数据有助于我们理解这些特性。
{"title":"Spatial lay-out of various smooth muscles.","authors":"Giorgio Gabella","doi":"10.1540/jsmr.57.19","DOIUrl":"https://doi.org/10.1540/jsmr.57.19","url":null,"abstract":"<p><p>The characteristic mechanical activities of the smooth muscles found in all organs of the body are highly variable and depend mainly on the spatial arrangement of the muscle cells and the stroma: mass, orientation, relationships, links, constraints, which are deployed in various configurations. These structural features are examined here for their mechanical relevance, in light and electron microscopic views of several muscles of viscera and blood vessels, in a selection of mammalian species. Smooth muscles are incompressible and therefore maintain constant volume. They do not have available space and any movement of a part requires displacement of another part. Most of them have no terminations or points of attachment, and in hollow organs such as intestines, blood vessels and uro-genital tract they usually form structures closed onto themselves, such as rings or bag-like containers In these situations, changes in the size of the lumen is achieved very efficiently by a concentric inward enlargement that accompanies muscle contraction. The longitudinal arrangement of collagen blocks an elongation of small blood vessels upon contraction, further enhancing the efficiency of lumen reduction. In other muscles, links between layers and special arrangements of the stroma allow both shortening and elongation of a tubular organ to occur. The mechanics of smooth muscles has many characteristic features (some unique, some shared with those of hydrostats, some at variance with other muscles) and histological data are a contribution to our understanding of these properties.</p>","PeriodicalId":39619,"journal":{"name":"Journal of Smooth Muscle Research","volume":"57 0","pages":"19-34"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/13/42/jsmr-57-019.PMC8443803.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39434010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5-HT2A, 5-HT1B/D, 5HT3 and 5-HT7 receptors as mediators of serotonin-induced direct contractile response of bovine airway smooth muscle. 5-HT2A, 5-HT1B/D, 5HT3和5-HT7受体作为血清素诱导的牛气道平滑肌直接收缩反应的介质。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.1540/jsmr.57.79
Darwin Da Costa Guevara, Ernesto Trejo

Background: Serotonin (5-hydroxytryptamine; 5-HT) performs a variety of functions in the body including the modulation of muscle tone in respiratory airways. Several studies indicate a possible role of 5-HT in the pathophysiology of bronchial hyperresponsiveness. However, the receptors and the molecular mechanisms by which 5-HT acts on airway smooth muscle (ASM) continue to be controversial. Most of the evidence suggests the participation of different subtypes of receptors in an indirect response. This study supports the proposal that 5-HT directly contracts ASM and characterizes pharmacologically the subtypes of serotonergic receptors involved. The characterization was carried out by using selective antagonists in an organ bath model allowing study of the smooth muscle of segments of bovine trachea.

Results: The results obtained show that 5-HT2A receptors are the main mediators of the direct contractile response of bovine ASM, with the cooperation of the 5-HT7, 5-HT3 and 5-HT1B/D receptors. Also, it was observed that the muscle response to serotonin is developed more slowly and to a lesser extent in comparison with the response to cholinergic stimulation.

Conclusion: Overall, the receptors that mediate the direct serotonergic contraction of the smooth muscle of the bovine trachea are 5-HT2A, 5-HT7, 5-HT3 and 5-HT1B/D receptors.

背景:5-羟色胺;5-羟色胺在体内发挥多种功能,包括调节呼吸道的肌肉张力。一些研究表明5-羟色胺可能在支气管高反应性的病理生理中起作用。然而,5-HT作用于气道平滑肌(ASM)的受体和分子机制仍然存在争议。大多数证据表明,不同亚型的受体参与了间接反应。这项研究支持了5-羟色胺直接收缩ASM的建议,并在药理学上表征了所涉及的5-羟色胺能受体亚型。表征是通过在器官浴模型中使用选择性拮抗剂进行的,该模型允许研究牛气管段的平滑肌。结果:结果表明,5-HT2A受体是牛ASM直接收缩反应的主要介质,并与5-HT7、5-HT3和5-HT1B/D受体协同作用。此外,观察到肌肉对血清素的反应比对胆碱能刺激的反应发展得更慢,程度也更小。结论:总的来说,介导牛气管平滑肌5-羟色胺能直接收缩的受体是5-HT2A、5-HT7、5-HT3和5-HT1B/D受体。
{"title":"5-HT<sub>2A</sub>, 5-HT<sub>1B/D</sub>, 5HT<sub>3</sub> and 5-HT<sub>7</sub> receptors as mediators of serotonin-induced direct contractile response of bovine airway smooth muscle.","authors":"Darwin Da Costa Guevara,&nbsp;Ernesto Trejo","doi":"10.1540/jsmr.57.79","DOIUrl":"https://doi.org/10.1540/jsmr.57.79","url":null,"abstract":"<p><strong>Background: </strong>Serotonin (5-hydroxytryptamine; 5-HT) performs a variety of functions in the body including the modulation of muscle tone in respiratory airways. Several studies indicate a possible role of 5-HT in the pathophysiology of bronchial hyperresponsiveness. However, the receptors and the molecular mechanisms by which 5-HT acts on airway smooth muscle (ASM) continue to be controversial. Most of the evidence suggests the participation of different subtypes of receptors in an indirect response. This study supports the proposal that 5-HT directly contracts ASM and characterizes pharmacologically the subtypes of serotonergic receptors involved. The characterization was carried out by using selective antagonists in an organ bath model allowing study of the smooth muscle of segments of bovine trachea.</p><p><strong>Results: </strong>The results obtained show that 5-HT<sub>2A</sub> receptors are the main mediators of the direct contractile response of bovine ASM, with the cooperation of the 5-HT<sub>7</sub>, 5-HT<sub>3</sub> and 5-HT<sub>1B/D</sub> receptors. Also, it was observed that the muscle response to serotonin is developed more slowly and to a lesser extent in comparison with the response to cholinergic stimulation.</p><p><strong>Conclusion: </strong>Overall, the receptors that mediate the direct serotonergic contraction of the smooth muscle of the bovine trachea are 5-HT<sub>2A</sub>, 5-HT<sub>7</sub>, 5-HT<sub>3</sub> and 5-HT<sub>1B/D</sub> receptors.</p>","PeriodicalId":39619,"journal":{"name":"Journal of Smooth Muscle Research","volume":"57 0","pages":"79-93"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/96/9a/jsmr-57-079.PMC8710915.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39785070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Myorelaxant and antispasmodic effect of an aqueous extract of Artemisia campestris L. via calcium channel blocking and anticholinergic pathways. 青蒿水提物通过钙通道阻断和抗胆碱能通路的肌肉松弛和抗痉挛作用。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.1540/jsmr.57.35
Mohamed Marghich, Ouafa Amrani, Hassane Mekhfi, Abderrahim Ziyyat, Mohamed Bnouham, Mohammed Aziz

Intestinal spasms are violent contractions that occur in the intestine, which cause discomfort to people who have them. Medicinal plants are widely used in traditional Moroccan medicine to treat these problems, among these being Artemisia campestris L. This study aims to evaluate the relaxant and antispasmodic effects of an aqueous extract of this plant (ACAE). It was performed in vitro on isolated segments of both isolated rat and rabbit jejunum mounted in an organ bath and tension recordings made via an isotonic transducer. ACAE caused a myorelaxant effect on baseline rabbit jejunum contractions in a dose-dependent and reversible manner with an IC50 of 1.52 ± 0.12 mg/ml. This extract would not act via adrenergic receptors pathway. On the other hand, the extract caused a dose-dependent relaxation of the jejunum tone in rat jejenum segments pre-contracted with either Carbachol (CCh; 10-6 M) or high K+ (KCl 75 mM) with an IC50 = 0.49 ± 0.02 mg/ml and 0.36 ± 0.02 mg/ml respectively. In the presence of different doses of the extract, the maximum response to CCh and CaCl2 was significantly reduced. This demonstrates that ACAE acts on both muscarinic receptors and voltage-dependent calcium channels. Thus, the plant extract acted on both muscarinic and nicotinic receptors and acts on the guanylate cyclase pathway, but not the nitric oxide pathway. These results indicate the mechanism by which Artemisia campestris L. acts as an effective antispasmodic agent in traditional Moroccan medicine.

肠痉挛是发生在肠道内的剧烈收缩,会给患者带来不适。药用植物在摩洛哥传统医学中被广泛用于治疗这些问题,其中包括青蒿(Artemisia campestris L.)。本研究旨在评估该植物水提取物(ACAE)的松弛和抗痉挛作用。在离体大鼠和家兔空肠的分离段上进行体外实验,并通过等渗换能器记录张力。ACAE对兔空肠收缩基线产生肌松弛作用,其IC50为1.52±0.12 mg/ml,呈剂量依赖性和可逆性。该提取物不通过肾上腺素能受体途径起作用。另一方面,该提取物引起大鼠空肠节段空肠张力的剂量依赖性松弛,这些空肠节段与Carbachol (CCh;10-6 M)或高K+ (KCl 75 mM), IC50分别为0.49±0.02 mg/ml和0.36±0.02 mg/ml。在不同剂量的提取物存在下,对CCh和CaCl2的最大反应显着降低。这表明ACAE作用于毒蕈碱受体和电压依赖性钙通道。因此,植物提取物作用于毒蕈碱和烟碱受体,并作用于鸟苷酸环化酶途径,但不作用于一氧化氮途径。这些结果提示了在摩洛哥传统医学中,campestris L.作为一种有效的抗痉挛药的机制。
{"title":"Myorelaxant and antispasmodic effect of an aqueous extract of Artemisia campestris L. via calcium channel blocking and anticholinergic pathways.","authors":"Mohamed Marghich,&nbsp;Ouafa Amrani,&nbsp;Hassane Mekhfi,&nbsp;Abderrahim Ziyyat,&nbsp;Mohamed Bnouham,&nbsp;Mohammed Aziz","doi":"10.1540/jsmr.57.35","DOIUrl":"https://doi.org/10.1540/jsmr.57.35","url":null,"abstract":"<p><p>Intestinal spasms are violent contractions that occur in the intestine, which cause discomfort to people who have them. Medicinal plants are widely used in traditional Moroccan medicine to treat these problems, among these being Artemisia campestris L. This study aims to evaluate the relaxant and antispasmodic effects of an aqueous extract of this plant (ACAE). It was performed in vitro on isolated segments of both isolated rat and rabbit jejunum mounted in an organ bath and tension recordings made via an isotonic transducer. ACAE caused a myorelaxant effect on baseline rabbit jejunum contractions in a dose-dependent and reversible manner with an IC<sub>50</sub> of 1.52 ± 0.12 mg/ml. This extract would not act via adrenergic receptors pathway. On the other hand, the extract caused a dose-dependent relaxation of the jejunum tone in rat jejenum segments pre-contracted with either Carbachol (CCh; 10<sup>-6</sup> M) or high K<sup>+</sup> (KCl 75 mM) with an IC<sub>50</sub> = 0.49 ± 0.02 mg/ml and 0.36 ± 0.02 mg/ml respectively. In the presence of different doses of the extract, the maximum response to CCh and CaCl<sub>2</sub> was significantly reduced. This demonstrates that ACAE acts on both muscarinic receptors and voltage-dependent calcium channels. Thus, the plant extract acted on both muscarinic and nicotinic receptors and acts on the guanylate cyclase pathway, but not the nitric oxide pathway. These results indicate the mechanism by which Artemisia campestris L. acts as an effective antispasmodic agent in traditional Moroccan medicine.</p>","PeriodicalId":39619,"journal":{"name":"Journal of Smooth Muscle Research","volume":"57 0","pages":"35-48"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/30/bd/jsmr-57-035.PMC8443802.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39434493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Glycogen accumulation in smooth muscle of a Pompe disease mouse model. 庞贝病小鼠模型平滑肌糖原积累。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.1540/jsmr.57.8
Angela L McCall, Justin S Dhindsa, Aidan M Bailey, Logan A Pucci, Laura M Strickland, Mai K ElMallah

Pompe disease is a lysosomal storage disease caused by mutations within the GAA gene, which encodes acid α-glucosidase (GAA)-an enzyme necessary for lysosomal glycogen degradation. A lack of GAA results in an accumulation of glycogen in cardiac and skeletal muscle, as well as in motor neurons. The only FDA approved treatment for Pompe disease-an enzyme replacement therapy (ERT)-increases survival of patients, but has unmasked previously unrecognized clinical manifestations of Pompe disease. These clinical signs and symptoms include tracheo-bronchomalacia, vascular aneurysms, and gastro-intestinal discomfort. Together, these previously unrecognized pathologies indicate that GAA-deficiency impacts smooth muscle in addition to skeletal and cardiac muscle. Thus, we sought to characterize smooth muscle pathology in the airway, vascular, gastrointestinal, and genitourinary in the Gaa-/- mouse model. Increased levels of glycogen were present in smooth muscle cells of the aorta, trachea, esophagus, stomach, and bladder of Gaa-/- mice, compared to wild type mice. In addition, there was an increased abundance of both lysosome membrane protein (LAMP1) and autophagosome membrane protein (LC3) indicating vacuolar accumulation in several tissues. Taken together, we show that GAA deficiency results in subsequent pathology in smooth muscle cells, which may lead to life-threatening complications if not properly treated.

庞贝病是一种由GAA基因突变引起的溶酶体贮积病,GAA基因编码酸性α-葡萄糖苷酶(GAA),这是溶酶体糖原降解所必需的酶。缺乏GAA会导致糖原在心脏和骨骼肌以及运动神经元中积累。FDA批准的唯一治疗庞贝病的方法是酶替代疗法(ERT),它可以提高患者的生存率,但也揭示了庞贝病以前未被认识到的临床表现。这些临床体征和症状包括气管支气管软化症、血管动脉瘤和胃肠道不适。总之,这些以前未被认识到的病理表明,gaa缺乏除了影响骨骼肌和心肌外,还影响平滑肌。因此,我们试图在Gaa-/-小鼠模型中表征气道、血管、胃肠道和泌尿生殖系统的平滑肌病理。与野生型小鼠相比,Gaa-/-小鼠的主动脉、气管、食道、胃和膀胱的平滑肌细胞中糖原水平升高。此外,溶酶体膜蛋白(LAMP1)和自噬体膜蛋白(LC3)的丰度均增加,表明在一些组织中存在液泡积累。综上所述,我们表明GAA缺乏会导致平滑肌细胞的后续病理,如果治疗不当,可能导致危及生命的并发症。
{"title":"Glycogen accumulation in smooth muscle of a Pompe disease mouse model.","authors":"Angela L McCall,&nbsp;Justin S Dhindsa,&nbsp;Aidan M Bailey,&nbsp;Logan A Pucci,&nbsp;Laura M Strickland,&nbsp;Mai K ElMallah","doi":"10.1540/jsmr.57.8","DOIUrl":"https://doi.org/10.1540/jsmr.57.8","url":null,"abstract":"<p><p>Pompe disease is a lysosomal storage disease caused by mutations within the GAA gene, which encodes acid α-glucosidase (GAA)-an enzyme necessary for lysosomal glycogen degradation. A lack of GAA results in an accumulation of glycogen in cardiac and skeletal muscle, as well as in motor neurons. The only FDA approved treatment for Pompe disease-an enzyme replacement therapy (ERT)-increases survival of patients, but has unmasked previously unrecognized clinical manifestations of Pompe disease. These clinical signs and symptoms include tracheo-bronchomalacia, vascular aneurysms, and gastro-intestinal discomfort. Together, these previously unrecognized pathologies indicate that GAA-deficiency impacts smooth muscle in addition to skeletal and cardiac muscle. Thus, we sought to characterize smooth muscle pathology in the airway, vascular, gastrointestinal, and genitourinary in the Gaa<sup>-/-</sup> mouse model. Increased levels of glycogen were present in smooth muscle cells of the aorta, trachea, esophagus, stomach, and bladder of Gaa<sup>-/-</sup> mice, compared to wild type mice. In addition, there was an increased abundance of both lysosome membrane protein (LAMP1) and autophagosome membrane protein (LC3) indicating vacuolar accumulation in several tissues. Taken together, we show that GAA deficiency results in subsequent pathology in smooth muscle cells, which may lead to life-threatening complications if not properly treated.</p>","PeriodicalId":39619,"journal":{"name":"Journal of Smooth Muscle Research","volume":"57 0","pages":"8-18"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d6/e1/jsmr-57-008.PMC8053439.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38895702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Anti-inflammatory mechanisms of the vascular smooth muscle PPARγ. 血管平滑肌PPARγ的抗炎机制。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.1540/jsmr.57.1
Masashi Mukohda, Hiroshi Ozaki

This review highlights molecular mechanisms of anti-inflammatory and protective effects of the nuclear transcription factor, peroxisome proliferator-activated receptor γ (PPARγ) in vascular tissue. PPARγ is an ubiquitously expressed nuclear factor, and well-studied in adipose tissue and inflammatory cells. Additionally, beneficial effects of vascular PPARγ's on atherosclerosis and vascular remodeling/dysfunction have been reported although the detailed mechanism remains to be completely elucidated. Clinical and basic studies have shown that the synthetic PPARγ ligands, thiazolidinediones (TZDs), have protective effects against cardiovascular diseases such as atherosclerosis. Recent studies utilizing genetic tools suggested that those protective effects of TZDs on cardiovascular diseases are not due to a consequence of improvement of insulin resistance, but may be due to a direct effect on PPARγ's in vascular endothelial and smooth muscle cells. In this review, we discuss proposed mechanisms by which the vascular PPARγ regulates vascular inflammation and remodeling/dysfunction especially in smooth muscle cells.

本文综述了核转录因子-过氧化物酶体增殖体激活受体γ (PPARγ)在血管组织中的抗炎和保护作用的分子机制。PPARγ是一种普遍表达的核因子,在脂肪组织和炎症细胞中被充分研究。此外,血管PPARγ对动脉粥样硬化和血管重塑/功能障碍的有益作用已被报道,但其详细机制仍有待完全阐明。临床和基础研究表明,合成的PPARγ配体噻唑烷二酮(TZDs)对动脉粥样硬化等心血管疾病具有保护作用。最近利用遗传工具的研究表明,TZDs对心血管疾病的保护作用不是由于改善胰岛素抵抗的结果,而可能是由于对血管内皮细胞和平滑肌细胞中的PPARγ的直接影响。在这篇综述中,我们讨论了血管PPARγ调节血管炎症和重塑/功能障碍的机制,特别是在平滑肌细胞中。
{"title":"Anti-inflammatory mechanisms of the vascular smooth muscle PPARγ.","authors":"Masashi Mukohda,&nbsp;Hiroshi Ozaki","doi":"10.1540/jsmr.57.1","DOIUrl":"https://doi.org/10.1540/jsmr.57.1","url":null,"abstract":"<p><p>This review highlights molecular mechanisms of anti-inflammatory and protective effects of the nuclear transcription factor, peroxisome proliferator-activated receptor γ (PPARγ) in vascular tissue. PPARγ is an ubiquitously expressed nuclear factor, and well-studied in adipose tissue and inflammatory cells. Additionally, beneficial effects of vascular PPARγ's on atherosclerosis and vascular remodeling/dysfunction have been reported although the detailed mechanism remains to be completely elucidated. Clinical and basic studies have shown that the synthetic PPARγ ligands, thiazolidinediones (TZDs), have protective effects against cardiovascular diseases such as atherosclerosis. Recent studies utilizing genetic tools suggested that those protective effects of TZDs on cardiovascular diseases are not due to a consequence of improvement of insulin resistance, but may be due to a direct effect on PPARγ's in vascular endothelial and smooth muscle cells. In this review, we discuss proposed mechanisms by which the vascular PPARγ regulates vascular inflammation and remodeling/dysfunction especially in smooth muscle cells.</p>","PeriodicalId":39619,"journal":{"name":"Journal of Smooth Muscle Research","volume":"57 0","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6b/18/jsmr-57-001.PMC7920819.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25433816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effect of acute sympathetic activation on leg vasodilation before and after endurance exercise. 急性交感神经激活对耐力运动前后腿部血管舒张的影响。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.1540/jsmr.57.
Alessandro Gentilin, Cantor Tarperi, Kristina Skroce, Antonio Cevese, Federico Schena

Vascular conductance (VC) regulation involves a continuous balance between metabolic vasodilation and sympathetic vasoconstriction. Endurance exercise challenges the sympathetic control on VC due to attenuated sympathetic receptor responsiveness and persistence of muscle vasodilation, especially in endurance athletes, predisposing them to blood pressure control dysfunctions. This study assessed whether acute handgrip-mediated sympathetic activation (SYMP) restrains sudden leg vasodilation before and after a half-marathon. Prior to, and within the 20 min following the race, 11 well-trained runners underwent two single passive leg movement (SPLM) tests to suddenly induce leg vasodilation, one without and the other during SYMP. Leg blood flow and mean arterial pressure were measured to assess changes in leg VC. Undertaking 60 sec of SYMP reduced the baseline leg VC both before (4.0 ± 1.0 vs. 3.3 ± 0.7 ml/min/mmHg; P=0.01; NO SYMP vs. SYMP, respectively) and after the race (4.6 ± 0.8 vs. 3.9 ± 0.8 ml/min/mmHg; P=0.01). However, SYMP did not reduce leg peak vasodilation immediately after the SPLM either before (11.5 ± 4.0 vs. 12.2 ± 3.8 ml/min/mmHg; P=0.35) or after the race (7.2 ± 2.0 vs. 7.3 ± 2.6 ml/min/mmHg; P=0.96). Furthermore, SYMP did not blunt the mean leg vasodilation over the 60 sec after the SPLM before (5.1 ± 1.7 vs. 5.9 ± 2.5 ml/min/mmHg; P=0.14) or after the race (4.8 ± 1.3 vs. 4.2 ± 1.5 ml/min/mmHg; P=0.26). This data suggest that the release of local vasoactive agents effectively opposes any preceding handgrip-mediated augmented vasoconstriction in endurance athletes before and after a half-marathon. Handgrip-mediated SYMP might improve normal vasoconstriction while athletes are still, but not necessarily while they move, as movements can induce a release of vasoactive molecules.

血管传导(VC)调节涉及代谢性血管舒张和交感血管收缩之间的持续平衡。耐力运动挑战了交感神经对VC的控制,因为交感神经受体的反应减弱,肌肉血管持续扩张,尤其是耐力运动员,使他们容易出现血压控制功能障碍。这项研究评估了急性手掌介导的交感神经激活(SYMP)是否能抑制半程马拉松前后的突然腿部血管舒张。在比赛前和比赛后20分钟内,11名训练有素的跑步者进行了两次单被动腿部运动(SPLM)测试,以突然诱导腿部血管舒张,一次没有,另一次在SYMP期间。测量腿部血流量和平均动脉压以评估腿部VC的变化。进行60秒的SYMP治疗前降低了基线腿部VC(4.0±1.0 vs. 3.3±0.7 ml/min/mmHg;P = 0.01;无SYMP vs. SYMP)和赛后(4.6±0.8 vs. 3.9±0.8 ml/min/mmHg;P = 0.01)。然而,SYMP在SPLM后和之前都没有立即降低腿部血管舒张峰值(11.5±4.0 vs 12.2±3.8 ml/min/mmHg;P=0.35)或赛后(7.2±2.0 vs. 7.3±2.6 ml/min/mmHg;P = 0.96)。此外,SYMP在SPLM后60秒内没有减弱腿部血管舒张的平均值(5.1±1.7 vs 5.9±2.5 ml/min/mmHg;P=0.14)或赛后(4.8±1.3 vs 4.2±1.5 ml/min/mmHg;P = 0.26)。这一数据表明,在耐力运动员半程马拉松前后,局部血管活性药物的释放有效地对抗任何先前的手握介导的血管收缩增强。当运动员静止时,手握介导的SYMP可能会改善正常的血管收缩,但在运动时却不一定,因为运动可以诱导血管活性分子的释放。
{"title":"Effect of acute sympathetic activation on leg vasodilation before and after endurance exercise.","authors":"Alessandro Gentilin,&nbsp;Cantor Tarperi,&nbsp;Kristina Skroce,&nbsp;Antonio Cevese,&nbsp;Federico Schena","doi":"10.1540/jsmr.57.","DOIUrl":"https://doi.org/10.1540/jsmr.57.","url":null,"abstract":"<p><p>Vascular conductance (VC) regulation involves a continuous balance between metabolic vasodilation and sympathetic vasoconstriction. Endurance exercise challenges the sympathetic control on VC due to attenuated sympathetic receptor responsiveness and persistence of muscle vasodilation, especially in endurance athletes, predisposing them to blood pressure control dysfunctions. This study assessed whether acute handgrip-mediated sympathetic activation (SYMP) restrains sudden leg vasodilation before and after a half-marathon. Prior to, and within the 20 min following the race, 11 well-trained runners underwent two single passive leg movement (SPLM) tests to suddenly induce leg vasodilation, one without and the other during SYMP. Leg blood flow and mean arterial pressure were measured to assess changes in leg VC. Undertaking 60 sec of SYMP reduced the baseline leg VC both before (4.0 ± 1.0 vs. 3.3 ± 0.7 ml/min/mmHg; P=0.01; NO SYMP vs. SYMP, respectively) and after the race (4.6 ± 0.8 vs. 3.9 ± 0.8 ml/min/mmHg; P=0.01). However, SYMP did not reduce leg peak vasodilation immediately after the SPLM either before (11.5 ± 4.0 vs. 12.2 ± 3.8 ml/min/mmHg; P=0.35) or after the race (7.2 ± 2.0 vs. 7.3 ± 2.6 ml/min/mmHg; P=0.96). Furthermore, SYMP did not blunt the mean leg vasodilation over the 60 sec after the SPLM before (5.1 ± 1.7 vs. 5.9 ± 2.5 ml/min/mmHg; P=0.14) or after the race (4.8 ± 1.3 vs. 4.2 ± 1.5 ml/min/mmHg; P=0.26). This data suggest that the release of local vasoactive agents effectively opposes any preceding handgrip-mediated augmented vasoconstriction in endurance athletes before and after a half-marathon. Handgrip-mediated SYMP might improve normal vasoconstriction while athletes are still, but not necessarily while they move, as movements can induce a release of vasoactive molecules.</p>","PeriodicalId":39619,"journal":{"name":"Journal of Smooth Muscle Research","volume":"57 0","pages":"53-67"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/da/a0/jsmr-57-053.PMC8592823.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39886143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Organ cross-sensitization mechanisms in chronic diseases related to the genitourinary tract. 泌尿生殖道相关慢性疾病的器官交叉致敏机制
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.1540/jsmr.57.49
Tsuyoshi Majima, Naoto Sassa

There are various refractory chronic inflammatory diseases related to the genitourinary tract, such as interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome. It has been reported that in the general population, these diseases are related to other chronic illnesses, such as irritable bowel syndrome or vulvodynia. Herein, we review papers regarding pelvic organ cross-sensitization, a factor which is considered to contribute to these relationships. Several other researchers and ourselves have reported that noxious stimuli from a diseased pelvic organ are transmitted to an adjacent normal structure via shared sensory neural pathways at the prespinal, spinal, and supraspinal levels, resulting in functional changes in the adjacent normal structure. In conclusion, since there are few treatments to cure interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome completely, further studies regarding organ cross-sensitization may provide new insights into the pathophysiology and treatment strategies for these diseases.

泌尿生殖系统有多种难治性慢性炎症性疾病,如间质性膀胱炎/膀胱痛综合征、慢性前列腺炎/慢性盆腔痛综合征等。据报道,在一般人群中,这些疾病与其他慢性疾病有关,如肠易激综合征或外阴痛。在此,我们回顾了有关盆腔器官交叉致敏的论文,这是一个被认为有助于这些关系的因素。其他几位研究人员和我们已经报道,来自病变盆腔器官的有害刺激通过脊柱前、脊柱和脊柱上水平的共享感觉神经通路传递到邻近的正常结构,导致邻近正常结构的功能改变。综上所述,由于完全治愈间质性膀胱炎/膀胱痛综合征和慢性前列腺炎/慢性盆腔痛综合征的治疗方法很少,进一步研究器官交叉致敏可能为这些疾病的病理生理和治疗策略提供新的见解。
{"title":"Organ cross-sensitization mechanisms in chronic diseases related to the genitourinary tract.","authors":"Tsuyoshi Majima,&nbsp;Naoto Sassa","doi":"10.1540/jsmr.57.49","DOIUrl":"https://doi.org/10.1540/jsmr.57.49","url":null,"abstract":"<p><p>There are various refractory chronic inflammatory diseases related to the genitourinary tract, such as interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome. It has been reported that in the general population, these diseases are related to other chronic illnesses, such as irritable bowel syndrome or vulvodynia. Herein, we review papers regarding pelvic organ cross-sensitization, a factor which is considered to contribute to these relationships. Several other researchers and ourselves have reported that noxious stimuli from a diseased pelvic organ are transmitted to an adjacent normal structure via shared sensory neural pathways at the prespinal, spinal, and supraspinal levels, resulting in functional changes in the adjacent normal structure. In conclusion, since there are few treatments to cure interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome completely, further studies regarding organ cross-sensitization may provide new insights into the pathophysiology and treatment strategies for these diseases.</p>","PeriodicalId":39619,"journal":{"name":"Journal of Smooth Muscle Research","volume":"57 0","pages":"49-52"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/75/a8/jsmr-57-049.PMC8495485.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39501035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Resistance of postprandial gastric functions and autonomic balance to taste stimulation. 餐后胃功能和自主平衡对味觉刺激的抵抗。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.1540/jsmr.57.68
Marek Waluga, Anna Kasicka-Jonderko, Marek Dzielicki, Magdalena Kamińska, Małgorzata Bożek, Joanna Laskowska, Joanna Palka, Daria Jurzak, Joanna Rusek, Krzysztof Jonderko

Exposure to unpleasant tastes leads to disturbances of interdigestive gastric myoelectrical activity (GMA) and may affect sympathetic/parasympathetic balance (SPB). We made a careful study to determine whether taste stimulation modulates the postprandial GMA, SPB, and gastric emptying (GE) of a solid meal. Eighteen healthy volunteers (9F/9M) entered the study. On six separate days, we recorded a four-channel electrogastrogram from each volunteer during a 35-min fasting period, then for 90 min after ingestion of a solid test meal of 300 kcal. GE was measured using a 13C-octanoic acid breath test. Heart rate variability (HRV) analysis was simultaneously performed. At the start of the 21st min after the test meal, subjects received an agar cube delivering either a sweet, salty, sour, or bitter taste, which they kept in the mouth for 35 min. Control procedures involved sessions performed with a tasteless agar cube, and without any stimulation. There was no effect of the experimental intervention upon the relative power share of particular GMA rhythms. Stimulation with the salty and the bitter taste evoked a statistically significant increase in the dominant frequency, whereas the sweet and sour taste did not affect it. Taste stimulation did not interfere with the meal-induced rise in the dominant power, nor affect slow wave coupling. The kinetics of the solid GE remained unchanged by the intervention. None of the taste stimulations affected the postprandial SPB. Taste stimulation elicited after ingestion of a meal, in contrast to that during a fast, did not adversely modify the postprandial pattern of either the GMA or SPB, nor affect the GE of solids.

暴露于不愉快的味道会导致消化间胃肌电活动(GMA)紊乱,并可能影响交感/副交感平衡(SPB)。我们做了一个仔细的研究,以确定味觉刺激是否调节餐后GMA, SPB和胃排空(GE)的固体餐。18名健康志愿者(9F/9M)进入研究。在6个不同的日子里,我们记录了每个志愿者在禁食35分钟期间的四通道胃电图,然后在摄入300千卡的固体测试餐后90分钟。采用13c -辛酸呼气试验测定GE。同时进行心率变异性(HRV)分析。在测试餐后的第21分钟开始,受试者收到一个琼脂立方体,其中有甜、咸、酸或苦的味道,他们将其放在嘴里35分钟。对照程序包括在没有任何刺激的情况下,用无味的琼脂立方体进行的会话。实验干预对特定GMA节奏的相对权力份额没有影响。咸味和苦味刺激诱发了显性频率的显著增加,而酸味和甜味对显性频率没有影响。味觉刺激不会干扰食物引起的主导功率的上升,也不会影响慢波耦合。固体GE的动力学在干预下保持不变。味觉刺激对餐后SPB没有影响。与禁食相比,在进食后引起的味觉刺激不会对餐后GMA或SPB的模式产生不利影响,也不会影响固体的GE。
{"title":"Resistance of postprandial gastric functions and autonomic balance to taste stimulation.","authors":"Marek Waluga,&nbsp;Anna Kasicka-Jonderko,&nbsp;Marek Dzielicki,&nbsp;Magdalena Kamińska,&nbsp;Małgorzata Bożek,&nbsp;Joanna Laskowska,&nbsp;Joanna Palka,&nbsp;Daria Jurzak,&nbsp;Joanna Rusek,&nbsp;Krzysztof Jonderko","doi":"10.1540/jsmr.57.68","DOIUrl":"https://doi.org/10.1540/jsmr.57.68","url":null,"abstract":"<p><p>Exposure to unpleasant tastes leads to disturbances of interdigestive gastric myoelectrical activity (GMA) and may affect sympathetic/parasympathetic balance (SPB). We made a careful study to determine whether taste stimulation modulates the postprandial GMA, SPB, and gastric emptying (GE) of a solid meal. Eighteen healthy volunteers (9F/9M) entered the study. On six separate days, we recorded a four-channel electrogastrogram from each volunteer during a 35-min fasting period, then for 90 min after ingestion of a solid test meal of 300 kcal. GE was measured using a <sup>13</sup>C-octanoic acid breath test. Heart rate variability (HRV) analysis was simultaneously performed. At the start of the 21st min after the test meal, subjects received an agar cube delivering either a sweet, salty, sour, or bitter taste, which they kept in the mouth for 35 min. Control procedures involved sessions performed with a tasteless agar cube, and without any stimulation. There was no effect of the experimental intervention upon the relative power share of particular GMA rhythms. Stimulation with the salty and the bitter taste evoked a statistically significant increase in the dominant frequency, whereas the sweet and sour taste did not affect it. Taste stimulation did not interfere with the meal-induced rise in the dominant power, nor affect slow wave coupling. The kinetics of the solid GE remained unchanged by the intervention. None of the taste stimulations affected the postprandial SPB. Taste stimulation elicited after ingestion of a meal, in contrast to that during a fast, did not adversely modify the postprandial pattern of either the GMA or SPB, nor affect the GE of solids.</p>","PeriodicalId":39619,"journal":{"name":"Journal of Smooth Muscle Research","volume":"57 0","pages":"68-78"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/78/cd/jsmr-57-068.PMC8710914.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39785068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Smooth Muscle Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1